The effort is publicly being labeled as sand"supplemental" to the emerging agenda being crafted on Capitol Hill, including the highly populist "Better Deal" proposal touted by party leaders in the House and Senate last month. But the new group's leaders do not see that agenda, including a push for lower prescription-drug prices, as particularly helpful to Democrats in exurban districts or key Midwestern states where President Trump won last year.